loading page

HPV Vaccine Trends and Attitudes since the COVID-19 Pandemic
  • Nisha Bharat,
  • Andrea Ziegler,
Nisha Bharat
Loyola University Chicago Stritch School of Medicine

Corresponding Author:[email protected]

Author Profile
Andrea Ziegler
Loyola University Medical Center
Author Profile
Loyola University Medical Center
Author Profile


Introduction: Vaccine hesitancy has historically played a large role in the low rate of the human papillomavirus (HPV) vaccine coverage in the United States and has further surfaced to the forefront of public discourse since the start of the COVID-19 pandemic. This study aims to determine how HPV vaccination attitudes and trends among primary care physicians and patients have changed since the COVID-19 pandemic. Design: Physicians and patients (aged 9-45) participated in a voluntary survey regarding HPV vaccination. In patients under 18 years of age, the survey was completed by the patient’s parent or guardian. Results: Of the 27 healthcare providers surveyed, 22.2% agreed that there has been an increase in misinformation about the HPV vaccine since the COVID-19 pandemic and 7.4% of providers believed that patients were less willing to discuss or receive the HPV vaccine. A majority of patients surveyed (87.7%) were aware of the HPV vaccine but only about a third of those patients had received all three doses of the vaccine (28.1%). Conclusion: Recent trends in receiving the HPV vaccine may be associated with the polarizing climate during the COVID-19 pandemic. Understanding how trends in vaccine hesitancy have changed since the pandemic will allow further and more targeted efforts to increase HPV vaccine uptake.